| The human tumor microbiome is composed of tumor type–specific intracellular bacteria D Nejman, I Livyatan, G Fuks, N Gavert, Y Zwang, LT Geller, ... Science 368 (6494), 973-980, 2020 | 1302 | 2020 |
| Proton channels and exchangers in cancer EP Spugnini, P Sonveaux, C Stock, M Perez-Sayans, A De Milito, S Avnet, ... Biochimica et Biophysica Acta (BBA)-Biomembranes 1848 (10), 2715-2726, 2015 | 208 | 2015 |
| Sarcoma treatment in the era of molecular medicine TGP Grünewald, M Alonso, S Avnet, A Banito, S Burdach, F Cidre‐Aranaz, ... EMBO molecular medicine 12 (11), e11131, 2020 | 190 | 2020 |
| Energy metabolism in osteoclast formation and activity S Lemma, M Sboarina, PE Porporato, N Zini, P Sonveaux, G Di Pompo, ... The international journal of biochemistry & cell biology 79, 168-180, 2016 | 180 | 2016 |
| MET Overexpression Turns Human Primary Osteoblasts into Osteosarcomas S Patane, S Avnet, N Coltella, B Costa, S Sponza, M Olivero, E Vigna, ... Cancer research 66 (9), 4750-4757, 2006 | 159 | 2006 |
| Biocompatibility of poly (D, L-lactide-co-glycolide) nanoparticles conjugated with alendronate E Cenni, D Granchi, S Avnet, C Fotia, M Salerno, D Micieli, MG Sarpietro, ... Biomaterials 29 (10), 1400-1411, 2008 | 152 | 2008 |
| Mesenchymal stroma: role in osteosarcoma progression M Cortini, S Avnet, N Baldini Cancer Letters 405, 90-99, 2017 | 139 | 2017 |
| Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients’ bed S Ferrari, F Perut, F Fagioli, A Brach Del Prever, C Meazza, A Parafioriti, ... Journal of translational medicine 11, 1-7, 2013 | 137 | 2013 |
| Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells G Bonuccelli, S Avnet, G Grisendi, M Salerno, D Granchi, M Dominici, ... Oncotarget 5 (17), 7575, 2014 | 135 | 2014 |
| Strawberry-derived exosome-like nanoparticles prevent oxidative stress in human mesenchymal stromal cells F Perut, L Roncuzzi, S Avnet, A Massa, N Zini, S Sabbadini, F Giampieri, ... Biomolecules 11 (1), 87, 2021 | 131 | 2021 |
| Cancer‐associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF‐κB activation S Avnet, G Di Pompo, T Chano, C Errani, A Ibrahim‐Hashim, RJ Gillies, ... International journal of cancer 140 (6), 1331-1345, 2017 | 131 | 2017 |
| Expression of an IGF‐I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells K Scotlandi, S Avnet, S Benini, MC Manara, M Serra, V Cerisano, ... International Journal of Cancer 101 (1), 11-16, 2002 | 131 | 2002 |
| Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma S Avnet, L Sciacca, M Salerno, G Gancitano, MF Cassarino, A Longhi, ... Cancer research 69 (6), 2443-2452, 2009 | 122 | 2009 |
| Increased osteoclast activity is associated with aggressiveness of osteosarcoma S Avnet, A Longhi, M Salerno, JM Halleen, F Perut, D Granchi, S Ferrari, ... International journal of oncology 33 (6), 1231-1238, 2008 | 110 | 2008 |
| Molecular basis of osteoclastogenesis induced by osteoblasts exposed to wear particles D Granchi, I Amato, L Battistelli, G Ciapetti, S Pagani, S Avnet, N Baldini, ... Biomaterials 26 (15), 2371-2379, 2005 | 108 | 2005 |
| The role of autophagy in the maintenance of stemness and differentiation of mesenchymal stem cells FV Sbrana, M Cortini, S Avnet, F Perut, M Columbaro, A De Milito, ... Stem Cell Reviews and Reports 12, 621-633, 2016 | 100 | 2016 |
| Therapeutic implications of tumor interstitial acidification I Kolosenko, S Avnet, N Baldini, J Viklund, A De Milito Seminars in cancer biology 43, 119-133, 2017 | 96 | 2017 |
| Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance S Avnet, S Lemma, M Cortini, P Pellegrini, F Perut, N Zini, K Kusuzaki, ... Oncotarget 7 (39), 63408, 2016 | 94 | 2016 |
| Tumor-activated mesenchymal stromal cells promote osteosarcoma stemness and migratory potential via IL-6 secretion M Cortini, A Massa, S Avnet, G Bonuccelli, N Baldini PloS one 11 (11), e0166500, 2016 | 92 | 2016 |
| Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastases M Salerno, E Cenni, C Fotia, S Avnet, D Granchi, F Castelli, D Micieli, ... Current cancer drug targets 10 (7), 649-659, 2010 | 90 | 2010 |
